Find your path to Bart
81 people in our graph share verified history with Bart — schools, employers, funds. One of them is your warm intro.
Roel BulthuisunlockedBart: together at BNP Paribas Fortis (2000)
×2Bart: together at Coave Therapeutics
Bart: together at UniD Manufacturing
×8Bart: together at BNP Paribas Fortis
About
Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.
Contact· self-published, not guessed
Experience
- FundPlusPartnercurrent2023 — present
- EyeD PharmaBoard Membercurrent2023 — presentLiege Metropolitan Area
- UniD ManufacturingBoard Membercurrent2023 — presentLiege Metropolitan Area
- Coave TherapeuticsBoard Membercurrent2023 — presentGreater Paris Metropolitan Region
- EPICS TherapeuticsBoard Membercurrent2024 — presentGosselies
- WOLLUXCEO2021 — 2023Kortrijk, Flemish Region, Belgium
- Koramic Visual CommunicationMember Of The Management Board2021 — 2023Mouscron, Walloon Region, Belgium
- Fortino Capital PartnersCFO2019 — 2020Antwerpen Berchem, Vlaanderen, België
- Ackermans & van HaarenFinance2016 — 2019
- Ernst&YoungIFRS2002 — 2016
- Wolters Kluwer Financial Services | FinArchBusiness Consultant2000 — 2002Greater Boston
- BNP Paribas FortisConsolidatie1996 — 2000
Skills & more
Financial Reporting10Financial Analysis2International Financial Reporting Standards (IFRS)Internal Controls5Finance1Financial Accounting4Accounting4Financial Audits3Management ConsultingCorporate Finance1IFRS18US GAAP2
+1 more
Internal AuditFrom Bart's professional profile.
Colleagues at Fund+
Caroline Goddeeris
Partner at Fund+
Chris Buyse
Board Member at Fund+
Désiré Collen
Honorary Chairman / Board Observer at Fund+
Diane De Wyngaert
Administrative Assistant at Fund+
François Fontaine
Board Member at Fund+
Halina Novak
Principal at Fund+
Kenneth Bonheure
Board Member at Fund+
Luc Debruyne
Chairman of the Board at Fund+
Frequently asked questions
- Who is Bart De Leeuw?
- Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.
- Where does Bart De Leeuw work?
- Bart De Leeuw is Partner/CFO at Fund+.
- Where did Bart De Leeuw go to school?
- Bart De Leeuw studied at HUB-KUBrussel.
Same school
Also attended HUB-KUBrussel1
Shared employers
Also worked at EyeD Pharma5
Also worked at Coave Therapeutics5
Also worked at Ernst&Young2,000
Tyler WilsonSenior Accountant at Felicis VenturesSandra SchwarzerInvestor at Index VenturesLinn Hege AuneInvestor at InvestinorTorjusInvestor at InvestinorAngela ToyPartner & COO at Golden Gate VenturesMahesha SubramaniamHead of Client Relations at Golden Gate Ventures
+ 1,994 more
Also worked at BNP Paribas Fortis54
Jane MacDonaldExecutive Assistant at Iris CapitalRoel BulthuisInvestor at SynconaScott WerthamerGlobal Head of Client and Product Solutions Group at Fortress Investment GroupPedro del PozoBoard Member at Axon Partners GroupHiram ClausInvestment Director at NPM Capital N.V.Brieuc de HultsInvestment Director at Korys
+ 48 more





































